Week 295 Review - Sold Ferrexpo on fears of Russia/Ukraine tensions

This week was pretty flat all round, but a 2p rise in OPTI:Optibiotix would have given me a decent gain if I hadn't cashed in my profits by selling FXPO:Ferrexpo following a dip in share price on increasing tension between Russia and Ukraine. I wasn't going to risk my healthy profit being lost. The overall effect was an improvement in the deficit between cost and value of £1,292 leaving it at £23,599, and a total portfolio value plus cash of £115,484.

Worst performer was JLP:Jubilee Metals for the second week in a row. This week they dropped 14% as more people banked profits and waited for news on copper production. My holding is still up by 246% so nothing to worry about. I just need to resist the temptation to sell more and hold on to my 60,000 remaining shares for the long term.

No shares rose by 5% or more this week, so Share of the Week goes to POLR:Polar Capital which climbed 4% to get to 700p and take my holding to 37% higher than when I bought it, which when you add the 6% dividend is a really good performance. Review date for these is the end of June, and I intend to hold them until that time as I don't anticipate the same panic dangers I had with FXPO:Ferrexpo.

A slight tick up but a long way to go.

Dragging the trend line down again.

Here's the ISA and shares portfolio after week 35 of year 6.

			Weekly Change
Cash	£13.54		+£0
Portfolio cost	£67,058.62		+£0
Portfolio sell value (bid price-commission)	£54,731.71	(-18.4%)	+£1,003.73
Potential profits	£6,393.67		-£360.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£4,629.22		+£0
Yr 6 projected avg monthly profit	£569.43	(16.4%)	-£16.75
Total Dividends	£1,343.15		+£0
Total Profit from sales	£25,055.83		+£0
Average monthly cash profit	£383.92	(11.0%)	-£1.31
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	63%		+0%

Drop in potential profits thanks to the dip in JLP:Jubilee Metals, which took some shine off the 2p increase in OPTI:Optibiotix. Long term performance still well ahead of target and will be for some time unless I realise a loss.

Hardly any change really

Need to make up around £6,000 to get back on the trend line.

The SIPP looks like this after week 279 overall and week 19 of year 6.

			Weekly Change
Cash	£1,228.73		+£1,021.29
Portfolio cost	£68,149.52		+£2,151.97
Portfolio sell value (bid price - commission)	£57,653.00	(-15.4%)	+£294.89
Potential profits	£3,391.44		-£1,031.92
Yr 6 Dividends	£433.05		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£5,085.38		+£973.28
Yr 6 projected avg monthly profit	£1,243.31	(35.0%)	+£165.24
Total Dividends	£2,500.13		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£20,544.82		+£973.28
Average monthly cash profit	£347.25	(9.8%)	+£13.93
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	52%		-1%

A lot more going on here. First of all I transferred £2,200 from my work pension and used some to buy another 1,202 shares in DDDD:4D Pharma at 110.38 costing £1,335.72 and the rest to buy 28,330 shares in TLOU:Tlou Energy at 3.02p costing £864.52. I want to get as many in DDDD as possible while they are this cheap, and I believe TLOU is heavily de-risked now and a bargain at this price.

I then got nervous about the increasing tensions on the Russia/Ukraine border and although my review date for FXPO:Ferrexpo isn't until May, I decided to bank my profits and sold my 562 shares at 355.4825p making £973.28 (95.9%) profit. I still have the special dividend to come and already have 10% from previous dividends, taking my total profit to over 100%. I used some of the cash to buy more DDDD:4D Pharma, getting 848 at 113.016p costing £967.33.

That leaves me £1,000 to do something else with, but I'm not sure what. I may hold it in case there's a chance to get back into FXPO:Ferrexpo at a much reduced price, I may buy more OPTI:Optibiotix or DDDD:4D Pharma, or I may get back into SBTX:SkinBioTherapeutics if the price drops far enough. Alternatively I do what I ought to do, and see what's top of the magic formula ranking.

Year 6 projected performance is even more daft now, but should stay well above 10% by the end of the year, and long term performance actually dropped 0.1% owing to the injection amount increasing, so we're marginally below target but I'm confident by the end of summer we'll be over 10%.

A bigger bounce here because the green line includes cash.

Pretty flat here as this doesn't recognise the cash. As with the ISA, we need about £6,000 to get back on the trend line.

The trading account looks like this after week 245 overall and week 37 of year 5

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,598.20	(-32.7%)	-£6.36
Potential profits	£0.00		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£651.51		+£0
Yr 5 projected avg monthly profit	£77.73	(39.3%)	-£2.16
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£17.65	(8.9%)	-£0.07
(Sold stocks profit + Dividends - Fees  / Months)

A flat week, which is a relief after the massive dip taken last week, although some recovery would be nice. It seems like ages ago I was selling every week and banking profits. Now even the best performer is 20% down, but I'm still hoping for a quick recovery from DDDD:4D Pharma when the Nasdaq shares are more widely available.

Continuing the downward trend

Well below the trend line.

What are the chances of me holding the £1,000 cash in my SIPP to the end of the week? Not great I suspect!

It feels like lots of my shares are on the cusp of something big, and just waiting for news. OPTI:Optibiotix on Sweetbiotix production and contracts, DDDD:4D Pharma when Nasdaq investors arrive, TLOU:Tlou Energy when the PPA is signed, JLP:Jubilee Metals on production of copper, and a rise in CAML:Central Asia Metals as we approach ex-dividend date. Lots to look forward to.